Jiangsu Hengrui Medicine
600276.SS
#508
Rank
HK$315.73 B
Marketcap
HK$49.50
Share price
-0.27%
Change (1 day)
3.42%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : HK$5.35 B

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total liabilities are HK$5.35 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jiangsu Hengrui Medicine - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31HK$4.46 B-1.22%
2021-12-31HK$4.52 B-3.55%
2020-12-31HK$4.68 B60.51%
2019-12-31HK$2.92 B-0.85%
2018-12-31HK$2.94 B16.99%
2017-12-31HK$2.51 B54.86%
2016-12-31HK$1.62 B19.36%
2015-12-31HK$1.36 B16.5%
2014-12-31HK$1.16 B61.66%
2013-12-31HK$0.72 B29.27%
2012-12-31HK$0.55 B3.01%
2011-12-31HK$0.54 B9.68%
2010-12-31HK$0.49 B30.64%
2009-12-31HK$0.37 B44.93%
2008-12-31HK$0.26 B-39.28%
2007-12-31HK$0.43 B115%
2006-12-31HK$0.20 B17.71%
2005-12-31HK$0.17 B-21.9%
2004-12-31HK$0.21 B-57.61%
2003-12-31HK$0.51 B38.24%
2002-12-31HK$0.37 B9.32%
2001-12-31HK$0.34 B